Survey of the status of iron and sclerostin in major Thalassemia Patients

Leila Moinzadeh; Mohammad Reza Keramati; Mohammad Taha Jalali; Bejan Keikhaei; Najmaldin Saki; Amal Saki Malehi; Zahra Mohammadi; Mohammad Mirdoraghi; Seyyede Fatemeh Shams; Mohammad Hadi Sadeghian

doi:10.18502/ijml.v5i4.155

Leila Moinzadeh
Mohammad Reza Keramati
Mohammad Taha Jalali
Bejan Keikhaei
Najmaldin Saki
Amal Saki Malehi
Zahra Mohammadi
Mohammad Mirdoraghi
Seyyede Fatemeh Shams
Mohammad Hadi Sadeghian

DOI: https://doi.org/10.18502/ijml.v5i4.155

Abstract

Background and Aims: Thalassemia is one the most prevalent genetic anemia in the world; homozygote patients usually suffer from severe disturbances. Osteopenia and osteoporosis are of various types of thalassemia complications which are increase in rate in patients with iron overload conditions. Sclerostin is a protein which enhances bone loss by inhibiting osteoblasts. The aim of this study was to measure sclerostin protein and its association with iron overload in major thalassemia patients.

Materials and Methods: Forty patients with major beta-Thalassemia and 40 healthy control individuals were includedin the study; Sclerostin protein and ferritin were evaluated using ELISA method.

Results: Mean sclerostin protein was 100.7 pg/ml, in the case group; it was 143.1 pg/ml in the control group.There was a significant differences between sclerostin protein in case and control groups (p= 0.015). The association of sclerostin and ferritin was not significant in the case group (p= 0.7), while it was meaningful in the control individuals (p= 0.037).

Conclusion: Our findings suggest that sclerostin protein can play an important role in the pathogenesis of osteoporosis.